RBM5 and neoplasm: To determine the potential mechanism of tumor growth inhibition in vivo, A549 xenograft treated with pcDNA3.1 control or pcDNA3.1-RBM5 were excised and analyzed by immunohistochemistry, H&E, and TUNEL staining.